NCT06986239 - Safety and Immunogenicity of PCV-LITE, a Low-dose of Pneumococcal Conjugate Vaccine With LiteVax Adjuvant | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

April 1, 2026

Study Completion Date

July 1, 2026

Conditions

Vaccine Reaction

Interventions

BIOLOGICAL

PCV-LITE

Fractional dose of pneumococcal polysaccharide conjugate vaccine without LiteVax Adjuvant (LVA)

BIOLOGICAL

PCV-LITE+LVA

Fractional dose of pneumococcal polysaccharide conjugate vaccine with 1 mg of LiteVax Adjuvant (LVA)

BIOLOGICAL

PCV20

Standard (full) dose of pneumococcal polysaccharide conjugate vaccine without LiteVax Adjuvant (LVA)

BIOLOGICAL

PCV20+LVA

Standard (full) dose of pneumococcal polysaccharide conjugate vaccine with LiteVax Adjuvant (LVA)